Methods for improved production of Rebaudioside D and Rebaudioside M
AssigneeEvolva SA
InventorsMichael Dalgaard Mikkelsen, Jorgen Hansen, Ernesto Simon, Federico Brianza, Angelika Semmler, Kim Olsson, Simon Carlsen, Louis Düring, Alexei Ouspenski, Paula Hicks
Life of this patent
Estimating the term…
Abstract
Methods for recombinant production of steviol glycoside and compositions containing steviol glycosides are provided herein.
Claims30
A method of producing a steviol glycoside composition in a cell culture, comprising growing a recombinant host cell, comprising:
- (a) a gene encoding a polypeptide capable of synthesizing geranylgeranyl pyrophosphate (GGPP) from farnesyl diphosphate (FPP) and isopentenyl diphosphate (IPP);
- (b) a gene encoding a polypeptide capable of synthesizing ent-copalyl diphosphate from GGPP;
- (c) a gene encoding a polypeptide capable of synthesizing ent-kaurene from ent-copalyl pyrophosphate;
- (d) a gene encoding a polypeptide capable of synthesizing ent-kaurenoic acid from ent-kaurene;
- (e) a gene encoding a polypeptide capable of synthesizing steviol from ent-kaurenoic acid;
- (f) a gene encoding a polypeptide capable of reducing cytochrome P450 complex;
- (g) a first gene encoding a first polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside;
- wherein the gene has a copy number of 2 or more;
- and
- wherein the first polypeptide comprises a polypeptide having 65% or greater sequence identity to the amino acid sequence set forth in SEQ ID NO:16;
- and
- a second gene encoding a second polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside;
- wherein the second polypeptide comprises a polypeptide having 90% or greater sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:15 or 86;
- (h) a gene encoding a polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of the steviol glycoside;
- (i) a gene encoding a polypeptide capable of glycosylating steviol or the steviol glycoside at its C-13 hydroxyl group;
- and
- (j) a gene encoding a polypeptide capable of glycosylating steviol or the steviol glycoside at its C-19 carboxyl group;
- under conditions in which the genes are expressed;
- wherein at least one of the genes is a recombinant gene;
- wherein the steviol glycoside comprises steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, stevioside, 1,2-bioside, Rebaudioside A, Rebaudioside B, Rebaudioside D, or Rebaudioside E;
- and
- wherein the steviol glycoside composition produced by the host cell comprises Rebaudioside M that is produced by the host cell at a concentration of at least about 600 mg/L of the cell culture;
- and further comprising isolating Rebaudioside M that is produced by the host cell from the cell culture.
A method of producing a steviol glycoside composition, comprising whole-cell bioconversion of plant-derived or synthetic steviol and/or steviol glycosides in a cell culture of a recombinant host cell using:
- (a) a first polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside;
- wherein the first polypeptide comprises a polypeptide having 65% or greater sequence identity to the amino acid sequence set forth in SEQ ID NO:16;
- and
- a second polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside;
- wherein the second polypeptide comprises a polypeptide having 90% or greater sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:15 or 86, a polypeptide having a substitution at residues 211 and 286 of SEQ ID NO:15, or a combination thereof;
- (b) a polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of the steviol glycoside, comprising a polypeptide having 50% or greater sequence identity to the amino acid sequence set forth in SEQ ID NO:2;
- (c) a polypeptide capable of glycosylating steviol or a steviol glycoside at its C-13 hydroxyl group, comprising a polypeptide having 55% or greater sequence identity to the amino acid sequence set forth in SEQ ID NO:26;
- and/or
- (d) a polypeptide capable of glycosylating steviol or a steviol glycoside at its C-19 carboxyl group, comprising a polypeptide having 55% or greater sequence identity to the amino acid sequence set forth in SEQ ID NO:19;
- wherein at least one of the polypeptides is a recombinant polypeptide expressed in the recombinant host cell;
- and producing the steviol glycoside composition thereby;
- wherein the steviol glycoside comprises steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, stevioside, 1,2-bioside, Rebaudioside A, Rebaudioside B, Rebaudioside D, or Rebaudioside E;
- and
- wherein the steviol glycoside composition comprises Rebaudioside M that is produced at a concentration of at least about 600 mg/L of the cell culture;
- and further comprising isolating the produced Rebaudioside M from the cell culture.
An in vitro method of producing a steviol glycoside composition, comprising adding:
- (a) a first polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside;
- wherein the first polypeptide comprises a polypeptide having 65% or greater sequence identity to the amino acid sequence set forth in SEQ ID NO:16;
- and
- a second polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of a steviol glycoside;
- wherein the second polypeptide comprises a polypeptide having 90% or greater sequence identity to the amino acid sequence set forth in any one of SEQ ID NOs:15 or 86, a polypeptide having a substitution at residues 211 and 286 of SEQ ID NO:15, or a combination thereof;
- and one or more of:
- (b) a polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, 19-O-glucose, or both 13-O-glucose and 19-O-glucose of the steviol glycoside;
- (c) a polypeptide capable of glycosylating steviol or the steviol glycoside at its C-13 hydroxyl group;
- or
- (d) a polypeptide capable of glycosylating steviol or the steviol glycoside at its C-19 carboxyl group;
- and a plant-derived or synthetic steviol precursor, a steviol, a steviol glycoside precursor, and/or a steviol glycoside to a reaction mixture;
- wherein at least one of the polypeptides is a recombinant polypeptide;
- and producing the steviol glycoside composition thereby;
- and
- wherein the steviol glycoside composition comprises Rebaudioside M that is produced at a concentration of at least about 600 mg/L of the reaction mixture;
- and further comprising isolating the produced Rebaudioside M from the reaction mixture.
Dependencies are inferred from the claim text.